CLDF Title
Home | Contact Us | Bookmark
Centers of Educational Expertise  
Slide Library Webcasts Conference Highlights

Release Date: 04/26/19

Expiration Date: 04/26/20

*This program has expired. CME credit is no longer available.

Target Audience:

This enduring activity has been designed to meet the educational needs of physicians, advanced practice providers, and allied health professionals who provide care for hospitalized patients with liver disease.

Learning Objectives:

After completing this program, participants should be better able to:

  • Understand the complications and the consequences of cirrhosis
  • Describe the economic, patient, and caregiver burdens associated with cirrhosis
  • Demonstrate the ability to properly treat the complications of cirrhosis and prevent recurrence

Accreditation Statement:

This enduring activity has been planned and implemented in accordance with the accreditation requirements and policies of the New Mexico Medical Society (NMMS) through the joint providership of Rehoboth McKinley Christian Health Care Services (RMCHCS), the Chronic Liver Disease Foundation (CLDF), and the Texas Gulf Coast Gastroenterological Society (TGCGS). RMCHCS is accredited by the NMMS to provide continuing medical education for physicians.

RMCHCS designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accredited by

Provided by

Supported by educational grants from Mallinckrodt Pharmaceuticals and Salix Pharmaceuticals.

Held in Conjunction with Hospital Medicine 2019, SHM's Annual Conference.





Robert Brown, Jr., MD, MPH

Breaking News in Chronic Liver Disease

Kimberly Brown, MD, FAST, FAASLD, AGAF

Diagnosing and Managing Cirrhosis and Complications

Steven Flamm, MD, FAASLD, FACG

Clinical Case Forum I: Current and Emerging Management Approaches for the Patient with HRS

Kimberly Brown, MD, FAST, FAASLD, AGAF

Clinical Case Forum II: Inpatient Care and Transition of Care Strategies for the HE Patient

Robert Brown, Jr., MD, MPH

Expert Panel Discussion / Q&A

Kimberly A. Brown, MD, FAST, FAASLD, AGAF

Professor of Medicine Wayne State University
Chief, Gastroenterology and Hepatology
Associate Medical Director,
Henry Ford Hosptial Transplant Institute
Henry Ford Hospital
Detroit, Michigan

Dr. Kimberly A. Brown is the Chief of Gastroenterology and Hepatology at Henry Ford Hospital in Detroit. She joined the Henry Ford Medical Group in 1995 as Medical Director of the Liver Transplant Program and was appointed Chief of the Division of Gastroenterology and Hepatology in 2003. In addition, she served as the Program Director for the GI Fellowship Program from 2003 to 2008. In 2016 she was appointed as the Associate Medical Director for the Henry Ford Hospital Transplant Institute.

Dr. Brown received her undergraduate degree from the University of Michigan in 1981. She completed her medical degree at Wayne State University in 1985. Dr. Brown completed both her residency in Internal Medicine as well as her fellowship in Gastroenterology at the University of Michigan in 1992 and was named Chief Medical Resident in 1984-85.

Dr. Brown is a member of the American Gastroenterogy Association, the American Association for the Study of Liver Disease, the American College of Gastroenterology and the American Society of Transplantation. She served on the Board of Governors of the Henry Ford Medical Group for 9 years, the Henry Ford Hospital and System Network Board and was past co-chair of the Michigan Chapter of the American Liver Foundation. She was a founding Board Member for the ABIM Liver Transplantation and Advanced Hepatology Board. She is past Treasurer and Board Member of the American Society of Transplantation and is involved with several committees for both the Society and Hospital. She is a past member of the UNOS Liver and Intestines Committee and previously served on the Executive Board for the Liver and Intestines Community of Practice for the AST. She is past associate editor for CLD journal. Currently, Dr. Brown is the Secretary for the AASLD and serves on multiple committees in that capacity.

As Chief of Gastroenterology and Hepatology and past Medical Director of Liver Transplantation, Dr. Brown sees and manages patients with complex liver disease both before and after liver transplantation. In conjunction with Dr. Abouljoud, she worked to develop the leading liver transplant program in the State of Michigan. As fellowship director, she managed a fellowship program of 16 GI/Liver fellows and continues to be involved in structuring and monitoring their education and academic success. Dr. Brown has trained over 110 fellows in advanced hepatology and transplantation. She has published over 70 articles, 110 abstracts and 8 book chapters/reviews and is a very active clinical investigator in viral hepatitis, advanced liver disease and post liver transplant management.

Speaker Disclosure

Honoraria recipient: Gilead, Pfizer and Merck.

Research to Institution: Allergan, Conatus, Gilead, and Novartis.

Robert Brown Jr., MD, MPH, AGAF

Gladys and Roland Harriman Professor of Medicine
Vice Chair for Mentorship and Academic Development
Clinical Chief, Division of Gastroenterology and Hepatology
Weill Cornell Medicine
New York, New York

Robert S. Brown, Jr., MD, MPH is Vice Chair of Mentorship and Academic Development and Clinical Chief of the Division of Gastroenterology and Hepatology in the Department of Medicine Weill Cornell Medical College in New York, New York. Dr. Brown is the Director of the Center for Liver Disease and Transplantation at New York-Presbyterian Hospital in New York.

Dr. Brown received his bachelor's degree from Harvard College, his medical degree from New York University and his Master of Public Health from the Graduate School of Public Health, University of California in Berkeley. Following the completion of his medical degree, he fulfilled his internship in Medicine at Beth Israel Hospital in Boston and his fellowship in gastroenterology and hepatology at the University of California in San Francisco.

Dr. Brown is an internationally known expert in liver disease and liver transplantation. He has co-authored over 170 peer-reviewed articles most dedicated to viral hepatitis and liver transplantation and has extensive research funding in those areas. He is an Associate Editor for Hepatology and published a book, "Common Liver Diseases and Transplantation: An Algorithmic Approach to Work-up and Management". He was awarded the Young Investigator Award from the American Society of Transplant Physicians, the Senior Attending Teacher Award from Columbia University Medical Center, and the American Liver Foundation New York Chapter's Physician of the Year.

Speaker Disclosure

Honoraria recipient: AbbVie, Dova, Gilead, Intercept, Merck and Shionogi, Inc.

Consultant/Research Support: AbbVie, Dova, Gilead, Intercept, Merck and Shionogi, Inc.

Steven Flamm, MD, FAASLD, FACG

Chief of Hepatology and Liver Transplantation Program
Professor of Medicine and Surgery
Northwestern Feinberg School of Medicine
Chicago, Illinois

Steven L. Flamm, MD is a Professor of Medicine and Surgery with the Division of Hepatology at Northwestern University Feinberg School of Medicine in Chicago, Illinois. He serves as the Chief of Transplantation Hepatology and Medical Director of Liver Transplantation.

Dr. Flamm received his MD degree from the University of Pennsylvania School of Medicine. He completed internal medicine training, a chief medical residency year, clinical fellowship in gastroenterology and a research fellowship in gastroenterology and hepatology at Beth Israel Hospital, Harvard Medical School, including a specialized year of training in liver transplantation at The Deaconess Hospital, Harvard Medical School.

Dr. Flamm is a member of the American Gastroenterological Association (AGA), American Association for the Study of Liver Diseases (AASLD), and is a fellow in the American College of Gastroenterology (ACG). He has served as the Region 7 Representative to the UNOS Liver and Intestine Committee and on the Publication and Practice Guidelines Committees of the AASLD. Currently, he is a trustee of the AASLD Foundation and chair of the AASLD Development Committee. Dr. Flamm is also currently a member of the Clinical Practice Guidelines Committee of the AGA, the Research Committee of the ACG, and the Illinois Hepatitis C State Task Force. He serves on the editorial board of Gastroenterology and Hepatology and is the Chair of an AGA abstract review committee.

Dr. Flamm has been the invited editor of three issues of Clinics in Liver Disease and was also the 2015 American Liver Foundation Illinois Chapter Honoree.

Dr. Flamm has published widely in the field of hepatic diseases and has spoken both nationally and internationally on many liver-related topics including viral hepatitis, autoimmune hepatitis, primary biliary cholangitis, hepatic encephalopathy, and liver transplantation. He has an active clinical research program for patients with many different chronic liver diseases including chronic viral hepatitis (HBV and HCV) hepatic encephalopathy, acute liver failure, primary biliary cholangitis and non-alcoholic fatty liver disease (NAFLD).

Speaker Disclosure

Honoraria recipient: Dova, and Salix Pharmaceuticals.

Consultant/Research Support: Dova, and Salix Pharmaceuticals.

Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
About CLDF
Mission Statement
Board of Trustees
Board of Advisors/Faculty
2019 GI Fellow Board of Advisors
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Substance Use Disorder
CLDF Follow Us
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2022 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.